Q: What are your thoughts on Viemed as a new position? Why are you negative on a couple of their large shareholders? Is this company a strong takeover candidate? Thanks!
Q: What is your opinion of Smith & Nephew? I need some non-Canadian healthcare in my portfolio. Would this be a reasonable purchase or would you recommend an alternative?
Q: Hi Peter & Ryan, I’m very light in the healthcare sector after recently selling JNJ. I rely on dividends to supplement my pension income and was looking at DR:CA, EXE:CA and SIA:CA. Can you please comment on each of these, quality of the companies, management, safety of the dividend etc. Feel free to suggest other names not listed Canadian or US. Dividend payers preferred. ( I already hold csh.un and used to own sis). Thanks. Mario
Q: Hi Peter and Team
The US will be able to import drugs from Cdn firms. Which firms would likely benefit the most and by how much?
Thanks for your excellent advice.
Q: This financing news really rubs me the wrong way. The issue price is deeply discounted and the units come with a warrant that is also really cheep assuming the company has any type of decent future. The insiders are participating. This looks like the insiders are taking advantage of the weak current share price to stuff their own pockets and the pockets of their buddies with cheep shares and warrants at the expense of longer term shareholders.
Q: COV has a history of private placements, this includes in 2013, 2017, and now. And insiders can buy provided the Venture exchange provides waivers, including fair value. With 22M common shares outstanding, the just announced offering waters down current shareholders by 10% and if the warrants are exericed, another 10%. WOW, management friendly or what?! Has management stated the use of these funds? And is management attempted to put a floor to the current decline? And as for the warrant exercise price, about 17.5 % higher the offer price, and over 5 years, is management saying the COV price will be range bound for years to come?.......oh, so many un-answered question......wish they would sit down with me for a java talk and provide direct responses!
......bewildering, eh?!.......Tom
Q: Regarding COV. I don't usually play with this stuff and I'd only be thinking about a 1% or so position. But there seems to be an actual business underneath this mess. So lets assume the Saudi business is gone and the rogue salesman pulled off whatever he was trying to pull off. As I read their reports that leaves 60% of their business in the US. So the question is where does that leave us going forward ? And how to assess managements ability to grow from there ? If it drops to the $2.00 range is there some value there ?
Q: Can you comment on COV's announcement to raise funds and what it means for company and shareholders. I have a very small position and based on your recent assessments, have stuck with this one. Are you still going to stick with the company or is it time to bail.
Q: Covalon has been beaten down considerably in last few months and I see from a few of the questions that 5i has been beaten up a bit over past recommendations on it. I think many investors are similar to myself in that when a trade works out well it is because I am very smart and when it doesn't work out well it is because someone else is not :-). However looking at Covalon it still seems like there is a good path forward for them but will take longer than originally anticipated. At today's depressed pricing would you consider them a good option from a longer term perspective?
Q: Good morning,
I would like to add a US health care name to my portfolio. Considering MDT or SYK. Which do you prefer or do you have a better idea? I currently own IHI.
Thanks, Dennis
Q: I have to express my concern regarding your response to Dave re: COV on 7/29. The comment that you take a "Portfolio Approach" and 5I "will not enter into debates on individual stocks" is the issue. My concern here is that I do not buy ALL of the stocks in a particular portfolio but do own many of them. By the sheer presence of a stock in a 5I portfolio suggests to me that you approve of the stock and are recommending it. I have held onto stocks far too long because it was retained in the portfolio. I consider if a stock remains in one of your portfolios it is a "Hold" recommendation from 5I. Am I wrong?